Navigation Links
Health Diagnostic Laboratory, Inc. (HDL, Inc.) Partners With Gamma Therapeutics to Offer Breakthrough Diagnostic Assay for Heart Attack and Stroke Risk
Date:3/1/2011

tures.

The launch of the partnership between HDL, Inc. and Gamma Therapeutics represents a combined effort to advance the preventative model for chronic disease management, based on a recent monumental shift in the way physicians test for life-threatening conditions. Moving beyond traditional lipid testing, HDL. Inc. is a market leader in providing comprehensive diagnostics capable of detecting risk factors predisposing patients to cardiovascular disease earlier than ever before possible.  

"The results are simple," said Tonya Mallory, CEO and Co-Founder of Virginia-headquartered HDL, Inc. "Thanks to advanced testing, it's now possible to reveal risk factors and biomarkers for cardiovascular and related diseases. The partnership with Gamma Therapeutics demonstrates HDL, Inc.'s ongoing goal to provide best of breed biomarkers, such as this new assay." Using a systematic approach to identify factors contributing to disease allows HDL, Inc. to provide its physicians with a better basis for effective treatment plans.

About HDL, Inc.

Health Diagnostic Laboratory Inc. (HDL, Inc.), a CAP accredited leader in health management, offers a comprehensive test menu of risk factors and biomarkers for cardiovascular and related diseases. Our systematic approach identifies factors contributing to disease and provides a basis for effective personalized treatment, allowing physicians to more effectively manage patients.  As an added value, patients receive a personalized overview of their risk factors along with intensive counseling from expert Health Coaches at no additional cost, improving compliance and enhancing potential outcomes. For more information, www.myhdl.com.

About Gamma Therapeutics, Inc.

Gamma Therapeutics, Inc., is an Oregon biotechnology venture developing a novel class of diagnostic test and surgical therapy solutions for the cardiovascular disease industry. 
'/>"/>

SOURCE Health Diagnostic Laboratory, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Tone Deafness Explained, from the Harvard Health Letter
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
8. ViroPharma to Present at Three Upcoming Healthcare Conferences
9. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
10. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
11. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Aug. 28, 2015  CytomX Therapeutics, Inc., a biopharmaceutical ... today announced the filing of a registration statement on ... (SEC) relating to a proposed initial public offering of ... offered and the price range for the offering have ... common stock under the symbol "CTMX" on the NASDAQ ...
(Date:8/28/2015)... Aug. 28, 2015 Research ... of the "Investigation Report on China,s Bevacizumab Market ... by Roche under the trade name of Avastin, bevacizumab ... In Feb.26, 2010, it was approved by CFDA to ... China all come from Roche ...
(Date:8/28/2015)... 2015  Today, in final recognition of the Centers ... Week, 1-800 Contacts is sharing how to keep lens ... wearers who do not properly care for their lens ... Most contact lens wearers understand the ... lens case is sometimes overlooked.  When proper steps to ...
Breaking Medicine Technology:CytomX Files Registration Statement for Proposed Initial Public Offering 2Investigation Report on China's Bevacizumab Market 2015-2019 21-800 Contacts Shares Tips on How to Clean Lens Cases 2
... SPRINT-1 study presented at AASLD annual meeting, ... patients and those,who failed prior treatment, SAN ... ) today reported that a planned interim analysis ... investigational oral hepatitis C,protease inhibitor, in combination with ...
... COPENHAGEN, Denmark, October 31 , - DoctorConsult ... That Improve Clinician Decision Making and Health Care ... workflow and more than a,century of experience as ... to provide interactive clinical reference and clinical decision,support ...
Cached Medicine Technology:Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 2Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 3Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 4Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 5Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 6Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 7Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 8Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 9Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 10Elsevier is Expanding eClinical Solutions in Europe 2Elsevier is Expanding eClinical Solutions in Europe 3
(Date:8/28/2015)... ... ... For Dallas, the time is nearing for the annual Heart Walk, and North ... American Heart Association hosts their well-known Heart Walk to raise money in awareness and ... be made. Walkers can participate in the cause and someone can also donate, even ...
(Date:8/28/2015)... ... 28, 2015 , ... As reported by Medical Daily on August 22 ... results that last for two years, the longest of any cellulite reduction system currently ... for a long-lasting, effective solution for their cellulite, according to Dr. Robert Weiss, director ...
(Date:8/28/2015)... Manistee, Michigan (PRWEB) , ... August 28, 2015 , ... ... in Western Michigan, joined as sponsor of the “Music With A Mission” benefit concert ... purpose behind the event was to raise money to support music education programs in ...
(Date:8/28/2015)... ... , ... Saint Petersburg, FL —Pocket Protein™, a protein beverage ... gluten, lactose or caffeine in a convenient 2 oz. pouch that never needs ... Awards. , Five consumer packaged goods (CPG) products were selected by the SupplySide ...
(Date:8/28/2015)... ... , ... Altima Technologies, Inc., the maker of popular NetZoom™ ... and audio-video devices, recently released Visio Stencils for the following product lines: ... VNX Series , Super Micro Computer SuperStorage, Hitachi Data Systems Virtual Storage Series, ...
Breaking Medicine News(10 mins):Health News:North Central Surgical Center’s Subsidiary Participates in Walk 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 2Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 3
... cell research, experts say , , MONDAY, Nov. 3 (HealthDay ... mice from mouse bodies that had been frozen for ... raise the specter of resurrecting lost species a la ... said recreating woolly mammoths was "probably impossible." , ...
... study conducted by researchers at Georgia State University is ... of preemptive morphine prior to a painful procedure in ... adult rodents. These studies have serious implications for ... prior to surgery. Infant rodents that did not receive ...
... efforts to educate the public about HIV, a new ... University and Children,s Hospital Boston has found that two-thirds ... spreading HIV in the home. , The qualitative study ... minor children, in families with an HIV-infected parent about ...
... at the University of California, San Diego (UCSD) are ... revving up the immune system to combat a particularly ... is being offered to patients with chronic lymphocytic leukemia ... to initial treatment or harbors a particular chromosomal abnormality ...
... which claimed that homeopathy is just a placebo, published in ... George Lewith, Professor of Health Research at Southampton University comments: ... nor of the various vital assumptions made about the data. ... homeopathy works for some conditions but not others, or change ...
... increases 32% to $16.0 million. - Heart valve therapy products revenue rises 39.1% ... surgical ablation products revenue grows 21.7%. - Third quarter gross profit ... 2008 revenue guidance to $65 - $66 ... million., MINNEAPOLIS, Nov. ...
Cached Medicine News:Health News:Scientists Make Clones of Mice Dead 16 Years 2Health News:GSU study first to confirm long-term benefits of morphine treatment in infants 2Health News:Study finds fears of HIV transmission in families with infected parent 2Health News:Moores UCSD Cancer Center studying novel leukemia vaccine for high-risk patients 2Health News:New evidence for homeopathy 2Health News:ATS Medical Announces Third Quarter Results 2Health News:ATS Medical Announces Third Quarter Results 3Health News:ATS Medical Announces Third Quarter Results 4Health News:ATS Medical Announces Third Quarter Results 5Health News:ATS Medical Announces Third Quarter Results 6Health News:ATS Medical Announces Third Quarter Results 7Health News:ATS Medical Announces Third Quarter Results 8
Thermometer for Round Water Bath...
... The F340 is a basic laboratory system ... pH results can be obtained when used ... 3-in-1 electrode. • Fast and easy one ... recognition for five buffers (pH 1.68, 4.00, ...
... - the multifunctional high-end microplate reader with ... detection modes., Fluorescence Intensity - FRET ... - HTRF, AlphaScreen , Luminescence ... dual emission microplate reader with fastest read ...
GENios Pro, TECANs advanced, multi-functional injector reader offers simultaneous reagent dispensing and detection for monitoring of fast kinetic reactions...
Medicine Products: